FDA Approves Pain Treatment for Cancer Patients

The Food and Drug Administration has approved the ExAblate MRI-guided focused ultrasound therapy to treat patients with pain from bone metastases.

Advertisement

The treatment, from InSightec, is designed to treat patients who are unable to undergo radiation treatment for their pain. It is a non-invasive, outpatient therapy and was approved for use in uterine fibroids patients in 2004.

More Articles on Pain Management:

5 Tips to Enhance Pain Specialist Communication With Primary Care Physicians

Dr. Jonathan Pedrick Joins OhioHealth

Study Examines Pain After Knee Surgery

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.